School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

DEXCOM INC DXCM

Healthcare · Medical - Devices

$84.11last close 2026-10-09 · market cap $31.74B · delayed data

Trailing returns

1M+0.27%
3M+15.19%
6M+28.06%
1Y+23.55%
5Y-36.41%

Basis: Adjusted daily closes.

What it does

DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners.

Open DXCM in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies